↓ Skip to main content

Long term enzyme replacement therapy for Fabry disease: effectiveness on kidney, heart and brain

Overview of attention for article published in Orphanet Journal of Rare Diseases, January 2013
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (94th percentile)
  • High Attention Score compared to outputs of the same age and source (95th percentile)

Mentioned by

news
1 news outlet
blogs
1 blog
policy
1 policy source
twitter
8 tweeters

Citations

dimensions_citation
93 Dimensions

Readers on

mendeley
90 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Long term enzyme replacement therapy for Fabry disease: effectiveness on kidney, heart and brain
Published in
Orphanet Journal of Rare Diseases, January 2013
DOI 10.1186/1750-1172-8-47
Pubmed ID
Authors

Saskia M Rombach, Bouwien E Smid, Machtelt G Bouwman, Gabor E Linthorst, Marcel G W Dijkgraaf, Carla E M Hollak

Abstract

Fabry disease is an X-linked lysosomal storage disorder caused by α-galactosidase A deficiency leading to renal, cardiac, cerebrovascular disease and premature death. Treatment with α-galactosidase A (enzyme replacement therapy, ERT) stabilises disease in some patients, but long term effectiveness is unclear.

Twitter Demographics

The data shown below were collected from the profiles of 8 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 90 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Spain 1 1%
Brazil 1 1%
Unknown 88 98%

Demographic breakdown

Readers by professional status Count As %
Researcher 15 17%
Student > Ph. D. Student 13 14%
Student > Bachelor 12 13%
Student > Master 11 12%
Other 9 10%
Other 19 21%
Unknown 11 12%
Readers by discipline Count As %
Medicine and Dentistry 35 39%
Agricultural and Biological Sciences 16 18%
Biochemistry, Genetics and Molecular Biology 7 8%
Neuroscience 4 4%
Computer Science 2 2%
Other 10 11%
Unknown 16 18%

Attention Score in Context

This research output has an Altmetric Attention Score of 22. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 03 October 2018.
All research outputs
#735,992
of 13,594,271 outputs
Outputs from Orphanet Journal of Rare Diseases
#66
of 1,496 outputs
Outputs of similar age
#8,687
of 148,592 outputs
Outputs of similar age from Orphanet Journal of Rare Diseases
#2
of 43 outputs
Altmetric has tracked 13,594,271 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 94th percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 1,496 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 7.1. This one has done particularly well, scoring higher than 95% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 148,592 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 94% of its contemporaries.
We're also able to compare this research output to 43 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 95% of its contemporaries.